Sanofi CFO on Growth Strategy, Valuation, Cost Cuts

The transcript discusses Sanofi's strategic focus under new leadership, emphasizing growth through both organic means and M&A activities. The company is leveraging its strong product pipeline, including Dupixent, to drive growth. Sanofi is also addressing its market position, aiming to align its stock valuation with peers. The company is confident in its competitive edge, particularly in allergy therapies, and is exploring opportunities in consumer healthcare. Financial targets include achieving a 30% operating margin by 2022, with a focus on execution and cost savings.

What is Sanofi's approach to growth under the new leadership?

• Discontinuing all current products

• Focusing solely on organic growth

• Relying only on mergers and acquisitions

• Combining organic growth with strategic acquisitions

How does Sanofi plan to convince the market of its value?

• By ignoring market trends

• By increasing its stock price arbitrarily

• By providing consistent proof points of execution

• By reducing its product line

What is Sanofi's approach to its stock valuation compared to its peers?

• To ignore market comparisons

• To align its valuation with peers through strategic actions

• To undervalue its stock intentionally

• To overvalue its stock without basis

What is a key component of Sanofi's strategy in the competitive landscape?

• Focusing on a single product

• Ignoring competitors

• Leveraging Dupixent's unique advantages

• Reducing research and development

What is the significance of Dupixent in Sanofi's strategy?

• It is central to their growth strategy

• It is a minor product

• It is being phased out

• It is only used for one indication

What is Sanofi's plan for its consumer healthcare business?

• To sell it off immediately

• To bring it back to growth

• To merge it with a competitor

• To discontinue it

What financial target has Sanofi set for 2022?

• A 50% operating margin

• A 30% operating margin

• A 10% increase in stock price

• A reduction in workforce